GLA
LLY icon

Good Life Advisors’s Eli Lilly LLY Stock Holding History

Good Life Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.2M Buy
2,818
+153
+6% +$119K 0.14% 131
2025
Q1 		$2.2M Sell
2,665
-52
-2% -$43.3K 0.16% 121
2024
Q4 		$2.1M Sell
2,717
-256
-9% -$212K 0.15% 127
2024
Q3 		$2.63M Buy
2,973
+374
+14% +$336K 0.16% 124
2024
Q2 		$2.35M Sell
2,599
-257
-9% -$206K 0.19% 99
2024
Q1 		$2.22M Buy
2,856
+480
+20% +$342K 0.2% 95
2023
Q4 		$1.39M Buy
2,376
+573
+32% +$334K 0.14% 130
2023
Q3 		$969K Sell
1,803
-7
-0.4% -$3.61K 0.11% 156
2023
Q2 		$849K Buy
1,810
+109
+6% +$45.7K 0.1% 166
2023
Q1 		$584K Sell
1,701
-205
-11% -$69.1K 0.07% 188
2022
Q4 		$697K Sell
1,906
-10
-0.5% -$3.55K 0.1% 167
2022
Q3 		$619K Buy
1,916
+245
+15% +$77.6K 0.09% 162
2022
Q2 		$542K Sell
1,671
-49
-3% -$14.7K 0.08% 179
2022
Q1 		$493K Sell
1,720
-147
-8% -$37.8K 0.06% 203
2021
Q4 		$516K Buy
1,867
+229
+14% +$58.1K 0.06% 207
2021
Q3 		$378K Buy
1,638
+332
+25% +$81.9K 0.05% 240
2021
Q2 		$300K Sell
1,306
-463
-26% -$93K 0.06% 226
2021
Q1 		$329K Buy
1,769
+367
+26% +$71.8K 0.07% 210
2020
Q4 		$236K Sell
1,402
-99
-7% -$14.8K 0.06% 224
2020
Q3 		$221K Buy
1,501
+100
+7% +$15.5K 0.06% 211
2020
Q2 		$228K Sell
1,401
-343
-20% -$52.6K 0.07% 210
2020
Q1 		$242K Buy
1,744
+121
+7% +$16.6K 0.09% 178
2019
Q4 		$215K Buy
+1,623
New +$188K 0.06% 239
2019
Q3 		– Sell
-1,926
Closed -$214K – 267
2019
Q2 		$214K Buy
1,926
+23
+1% +$2.71K 0.06% 224
2019
Q1 		$245K Buy
+1,903
New +$231K 0.07% 194

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Good Life Advisors's LLY Position: Q2 2025 in Review

Good Life Advisors increased its Eli Lilly (LLY) stake by 5.7% in Q2 2025, buying an estimated $119K and bringing the position to 2,818 shares worth $2.2M. The position accounts for 0.14% of the portfolio, ranked #131.

Good Life Advisors first reported a position in LLY in Q1 2019 and has held it in 25 quarters since. The position peaked at $2.63M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Good Life Advisors held 2,818 shares of Eli Lilly worth $2.2M as of Q2 2025.
  • Good Life Advisors bought 153 Eli Lilly shares in Q2 2025, an estimated $119K.
  • Eli Lilly made up 0.14% of Good Life Advisors's portfolio in Q2 2025, its #131 holding.
  • Good Life Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 25 quarters since.
  • Good Life Advisors's Eli Lilly position peaked at $2.63M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.